Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | EDNRA | P25101 | 2/20 | 0.37 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levosemotiadil SCHEMBL678293 | 1.00 | CYP3A4 (0.68) | CYP3A4EDNRACACNA1SDRD2DRD3 | |
| Semotiadil SCHEMBL80715 | 1.00 | CYP3A4 (0.68) | CYP3A4EDNRACACNA1SDRD2DRD3 | |
| Semotiadil SCHEMBL29396077 | 1.00 | CYP3A4 (0.68) | CYP3A4EDNRACACNA1SDRD2DRD3 | |
| SCHEMBL7376974 | 0.98 | CYP3A4 (0.65) | CYP3A4EDNRACACNA1SDRD2DRD3 | |
| SCHEMBL10676730 | 0.98 | CYP3A4 (0.65) | CYP3A4EDNRACACNA1SDRD2DRD3 | |
| Oxalic Acid SCHEMBL9748438 | 0.96 | CYP3A4 (0.66) | CYP3A4EDNRADRD2DRD3MAPK1 | |
| Semotiadil SCHEMBL7382921 | 0.94 | CYP3A4 (0.64) | CYP3A4EDNRADRD2DRD3MEN1 | |
| Levosemotiadil SCHEMBL30873510 | 0.94 | CYP3A4 (0.64) | CYP3A4EDNRADRD2DRD3MEN1 | |
| Semotiadil SCHEMBL7299290 | 0.94 | CYP3A4 (0.64) | CYP3A4EDNRADRD2DRD3MEN1 | |
| Semotiadil SCHEMBL7299286 | 0.94 | CYP3A4 (0.64) | CYP3A4EDNRADRD2DRD3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104203985-A | Cyclodextrin-based polymers for therapeutic delivery | CERULEAN PHARMA INC | 2014-12-10 | — | — | CN | claimed |
| CN-1315945-A | Nitrate salts of antihypertensive drugs | NICOX SA (FR) | 2001-10-03 | — | — | CN | claimed |
| EP-0429676-B1 | DRUG FOR IMPROVING BRAIN FUNCTION | SANTEN PHARMACEUTICAL CO LTD (JP) | 1996-09-18 | — | — | EP | claimed |
| US-5182276-A | NOOTROPIC AGENT | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1993-01-26 | — | — | US | claimed |
| EP-0237573-B1 | NOVEL BENZOTHIAZINE DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1992-01-15 | — | — | EP | claimed |
| EP-0429676-A1 | DRUG FOR IMPROVING BRAIN FUNCTION | SANTEN PHARMACEUTICAL CO., LTD (JP) | 1991-06-05 | — | — | EP | claimed |
| US-4786635-A | THERAPEUTIC AGENTS FOR CIRCULATORY DISEASES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1988-11-22 | — | — | US | claimed |
| JP-9012576-A | — | — | None | — | — | JP | disclosed |
| JP-8319237-A | — | — | None | — | — | JP | disclosed |
| JP-3227981-A | — | — | None | — | — | JP | disclosed |
| JP-3227929-A | — | — | None | — | — | JP | disclosed |
| CN-105399751-A | BUPRENORPHINE ANALOGS | PURDUE PHARMA LP | 2016-03-16 | — | — | CN | disclosed |
| CN-103380119-B | As the amino butyric acid derivative be substituted of enkephalinase inhibitor | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2016-02-17 | — | — | CN | disclosed |
| JP-H0912576-A | PRODUCTION OF BENZOTHIAZINE DERIVATIVE | SANTEN PHARMACEUT CO LTD | 1997-01-14 | — | — | JP | disclosed |
| JP-H08319237-A | THERAPEUTIC AGENT FOR NETTED CHOROIDEA DISEASE | SANTEN PHARMACEUT CO LTD | 1996-12-03 | — | — | JP | disclosed |
| EP-0237573-B1 | NOVEL BENZOTHIAZINE DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1992-01-15 | — | — | EP | disclosed |
| JP-H03227929-A | DIURETICS | SANTEN PHARMACEUT CO LTD | 1991-10-08 | — | — | JP | disclosed |
| JP-H03227981-A | CARDIOVASCULAR DISEASE REMEDY | SANTEN PHARMACEUT CO LTD | 1991-10-08 | — | — | JP | disclosed |
| US-4786635-A | THERAPEUTIC AGENTS FOR CIRCULATORY DISEASES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1988-11-22 | — | — | US | disclosed |
| EP-0237573-A1 | NOVEL BENZOTHIAZINE DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1987-09-23 | — | — | EP | disclosed |